drugset / Trial / NCT00796965

Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy Subjects

NCT00796965

Phase 1 Completed 48 enrolled AstraZeneca
RandomizedSingle-groupTriple-blind

Summary

Single Ascending Dose Study

Timeline

Start
2008-12
Primary completion
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7268 Small molecule Oral

Indications

No indication recorded.